Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists mine 1,100 patient records to spot thyroid cancer return risks

NCT ID NCT07695974

Completed Knowledge-focused Sponsor: University of Roma La Sapienza Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study examines medical records from over 1,100 adults who had papillary thyroid cancer and were declared cancer-free after initial treatment. Researchers want to identify which patient characteristics—such as age, tumor size, or cancer spread—are linked to a higher chance of the cancer coming back. No new treatments or tests are given; the team simply reviews existing data to find patterns that could improve follow-up care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better identify which thyroid cancer patients need closer monitoring after treatment.
What could go wrong
This is an observational study that looks back at past data, so it cannot prove cause and effect. The findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Thyroid Cancer, Papillary thyroid gland papillary carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAPILLARY THYROID CARCINOMA RECURRENCE FREE SURVIVAL

Contacts and locations

Locations

  • Sapienza University of Rome - Policlinico Umberto I Hospital

    Roma, 00161, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.